Cadila Healthcare reported 51.65 per cent rise in its consolidated net profit at Rs 278.09 crore for the quarter ended September 30 on the back of robust sales.
The company had posted a net profit after taxes, minority interest and share in profit/(loss) of associates at Rs 183.37 crore for the corresponding period of the previous fiscal, Cadila Healthcare said in a filing to the BSE.
Consolidated total income of the company also rose to Rs 2,108 crore for the quarter under consideration as against Rs 1,746.79 crore for the same period a year—ago, it added.
Cadila Healthcare, part of the Zydus group, provides healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products.
